🔗 Permalink

Inventor profile of:

Matthew J. Lamarche

City:

Reading, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2024-06-20

Top Assignees for applications by Matthew J. Lamarche

The entities that hold a legal rights for patent applications filed by inventor Lamarche Matthew J.:

NOVARTIS AG 23 Basel, Switzerland
Millennium Pharmaceuticals, Inc. 4 Cambridge, MA United States
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 3 PHILADELPHIA, PA United States
The General Hospital Corporation 1 Boston, MA United States
Abbott Laboratories 1 Abbott Park, IL United States
NOVARTIS AG 1 Emeryville, CA United States

Recent patent applications by Lamarche Matthew J.

Matthew J. Lamarche from Reading, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-06-20

US20240199609A1

Chemistry; metallurgy

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

#2 | 2022-12-15

US20220396585A1

Chemistry; metallurgy

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

#3 | 2022-11-03

US20220348553A1

Chemistry; metallurgy

1-PYRIDAZIN-/TRIAZIN-3-YL-PIPER(-AZINE)/IDINE/PYROLIDINE DERIVATIVES AND COMPOSITIONS THEREOF FOR INHIBITING THE ACTIVITY OF SHP2

#4 | 2022-08-04

US20220241277A1

Human necessities

Pharmaceutical combination comprising an ALK inhibitor and a SHP2 inhibitor

#5 | 2022-03-24

US20220089597A1

Chemistry; metallurgy

COMPOUNDS AND COMPOSITIONS FOR INHBITING THE ACTIVITY OF SHP2

#6 | 2022-03-10

US20220073537A1

Chemistry; metallurgy

N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

#7 | 2021-12-02

US20210371429A1

Chemistry; metallurgy

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

#8 | 2021-10-07

US20210309663A1

Chemistry; metallurgy

COMPOUNDS AND COMPOSITIONS FOR INHBITING THE ACTIVITY OF SHP2

#9 | 2021-09-30

US20210300919A1

Chemistry; metallurgy

Compounds and compositions for inhibiting the activity of SHP2

#10 | 2020-11-26

US20200369643A1

Chemistry; metallurgy

1-Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2

#11 | 2020-06-11

US20200181168A1

Chemistry; metallurgy

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

#12 | 2020-01-02

US20200002330A1

Chemistry; metallurgy

Compounds and compositions for inhibiting the activity of SHP2

#13 | 2019-11-14

US20190343836A1

Human necessities

PHARMACEUTICAL COMBINATION COMPRISING AN ALK INHIBITOR AND A SHP2 INHIBITOR

#14 | 2019-06-20

US20190185475A1

Chemistry; metallurgy

Compounds and compositions for inhibiting the activity of SHP2

#15 | 2018-12-20

US20180362496A1

Chemistry; metallurgy

1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2

#16 | 2018-09-06

US20180251471A1

Chemistry; metallurgy

Compounds and compositions for inhibiting the activity of SHP2

#17 | 2018-07-19

US20180201623A1

Chemistry; metallurgy

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

#18 | 2018-07-05

US20180186770A1

Chemistry; metallurgy

Compounds and compositions for inhibiting the activity of SHP2

#19 | 2018-03-08

US20180065949A1

Chemistry; metallurgy

1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2

#20 | 2018-03-08

US20180064709A1

Human necessities

Pharmaceutical combinations

#21 | 2017-07-20

US20170204080A1

Chemistry; metallurgy

1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2

#22 | 2017-01-19

US20170015704A1

Chemistry; metallurgy

AMINOTHIAZOLES AND THEIR USES

#23 | 2017-01-19

US20170015680A1

Chemistry; metallurgy

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

#24 | 2017-01-05

US20170001975A1

Chemistry; metallurgy

1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2

#25 | 2014-09-18

US20140274878A1

Chemistry; metallurgy

Aminothiazoles and their uses

#26 | 2013-09-26

US20130252883A1

Chemistry; metallurgy

Macrocycles and their uses

#27 | 2013-09-05

US20130231275A1

Human necessities

AMINIOTHIAZOLES AND THEIR USES

#28 | 2010-01-26

US10296138

Compounds which mimic the chemical and biological properties of discodermolide

#29 | 2009-07-23

US20090187031A1

Chemistry; metallurgy

Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof

#30 | 2009-07-23

US20090186830A1

Chemistry; metallurgy

Macrocycles and their uses

#31 | 2009-06-18

US20090156628A1

Chemistry; metallurgy

Aminothiazoles and their uses

#32 | 2008-09-11

US20080221142A1

Chemistry; metallurgy

EFTU inhibitors or aminothiazoles and their uses

#33 | 2007-06-28

US20070149533A1

Chemistry; metallurgy

Bicyclic compounds with kinase inhibitory activity

#34 | 2007-02-22

US20070043223A1

Chemistry; metallurgy

Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof

#35 | 2006-07-20

US20060160803A1

Chemistry; metallurgy

Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity

#36 | 2006-02-16

US20060035920A1

Chemistry; metallurgy

Chk-1 inhibitors

#37 | 2005-11-03

US20050245563A1

Chemistry; metallurgy

Chk-1 inhibitors

#38 | 2005-07-26

US10459682

Antagonists of melanin concentrating hormone receptor

InventorID:

425381 ⎘